Companies › IMRX

IMMUNEERING CORP (IMRX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001790340 · EDGAR filings · Updated 2026-07-28

IMMUNEERING CORP (IMRX) has reported institutional ownership of 45.1%, with 94 institutional managers holding positions valued at $153.7M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-28 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — Insider transaction reported (Form 4)
• 2026-07-16 — Initial insider ownership filed (Form 3)
• 2026-06-24 — Insider transaction reported (Form 4)
• 2026-06-16 — Insider transaction reported (Form 4)
• 2026-06-15 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IMMUNEERING CORP has 94 institutional holders and institutional ownership of 45.1%.

Insider activity

Insiders reported 27 transactions (23 buys, 0 sells) across 9 reporting insiders, with a net reported value of $721.4K.

Data flags from SEC filings

Related companies

PULSE BIOSCIENCES INC (PLSE) · NIAGEN BIOSCIENCE INC (NAGE) · EUPRAXIA PHARMACEUTICALS INC (EPRX) · DELCATH SYS INC (DCTH) · ORGANOGENESIS HLDGS INC (ORGO) · KORRO BIO INC (KRRO)